The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Acute and long-term treatment of mixed states in bipolar disorder
The DOI matches its Crossref record; 335 of the 335 references it cites were found in a registry or an index.
Abstract
OBJECTIVES: Although clinically highly relevant, the recognition and treatment of bipolar mixed states has played only an underpart in recent guidelines. This WFSBP guideline has been developed to supply a systematic overview of all scientific evidence pertaining to the acute and long-term treatment of bipolar mixed states in adults. METHODS: Material used for these guidelines is based on a systematic literature search using various data bases. Their scientific rigour was categorised into six levels of evidence (A-F), and different grades of recommendation to ensure practicability were assigned. We examined data pertaining to the acute treatment of manic and depressive symptoms in bipolar mixed patients, as well as data pertaining to the prevention of mixed recurrences after an index episode of any type, or recurrence of any type after a mixed index episode. RESULTS: Manic symptoms in bipolar mixed states appeared responsive to treatment with several atypical antipsychotics, the best evidence resting with olanzapine. For depressive symptoms, addition of ziprasidone to treatment as usual may be beneficial; however, the evidence base is much more limited than for the treatment of manic symptoms. Besides olanzapine and quetiapine, valproate and lithium should also be considered for recurrence prevention. LIMITATIONS: The concept of mixed states changed over time, and recently became much more comprehensive with the release of DSM-5. As a consequence, studies in bipolar mixed patients targeted slightly different bipolar subpopulations. In addition, trial designs in acute and maintenance treatment also advanced in recent years in response to regulatory demands. CONCLUSIONS: Current treatment recommendations are still based on limited evidence, and there is a clear demand for confirmative studies adopting the DSM-5 specifier with mixed features concept.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This is also congruent with current recommendations for augmentation in patients with unipolar TRD by the World Federation of Societies of Biological Psychiatry Task Force which considers lithium as first-line agent and aripiprazole and quetiapine as alternatives (Grunze et al., 2018).”
From Augmentation strategies for treatment resistant major depression: A systematic review and network meta-analysis (2022) · cites this paper as Grunze et al., 2018
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
Diagnostic and Statistical Manual of Mental Disorders, 5th ed.
Carter, M. J. (2014) · Therapeutic Recreation Journal · Cited by 15,169
Diagnostic and Statistical Manual of Mental Disorders
&NA; (1988) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-198802020-00022 · Cited by 12,526
Diagnostic and Statistical Manual of Mental Disorders, 3rd ed
COOPER, A. M., & MICHELS, R. (1981) · American Journal of Psychiatry · doi:10.1176/ajp.138.1.128 · Cited by 7,356
Yatham, L., & Malhi, G. (2011) · Oxford University Press eBooks · doi:10.1093/med/9780199562305.001.0001 · Cited by 3,506
Self-citationSelective publication of antidepressant trials and its influence on apparent efficacy
Turner, E. H., Matthews, A. M., Linardatos, E., Tell, R. A., & Rosenthal, R. (2008) · New England Journal of Medicine · doi:10.1056/nejmsa065779 · Cited by 2,435 · cited 2×
“The task force is aware of several inherent limitations of these guidelines: namely publication bias (Turner et al. 2008; Flint et al. 2015), sponsor bias (Lundh et al.”
BackgroundGrande, I., Berk, M., Birmaher, B., & Vieta, E. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00241-x · Cited by 1,710
Self-citationGoodwin, G., Haddad, P., Ferrier, I., Aronson, J., Barnes, T., Cipriani, A., Coghill, D., Fazel, S., Geddes, Jr., Grunze, H., et al. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116636545 · Cited by 1,309 · cited 5×
“This decision of the task force is also in line with their appreciation in other recent bipolar guidelines, such as the British Association for Psychopharmacology guideline (Goodwin et al. 2016).”
MethodResultInfluentialSelf-citationA consumer's guide to subgroup analyses
Oxman, A. D., & Guyatt, G. H. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-1-78 · Cited by 914 · cited 1×
“Post hoc secondary analyses play a prominent role in studies including manic and mixed manic patients but bear the risk of inflating the chance of false-positive findings (Oxman and Guyatt 1992).”
BackgroundTohen, M., Vieta, E., Calabrese, J., Ketter, T. A., Sachs, G., Bowden, C., Mitchell, P. B., Centorrino, F., Risser, R., Baker, R. W., et al. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.11.1079 · Cited by 908
Self-citationMorrow, J. (2006) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2005.074203 · Cited by 880 · cited 1×
“Despite an FDA pregnancy category ‘C’ rating, a teratogenic risk with lamotrigine treatment is suggested at doses exceeding 200mg/day (Morrow et al. 2006).”
BackgroundBandelow, B., Zohar, J., Hollander, E., Kasper, S., Möller, H.-J., WFSBP TASK FORCE ON TREATMENT GUIDE, Bandelow, B., Zohar, J., Hollander, E., Kasper, S., et al. (2008) · The World Journal of Biological Psychiatry · doi:10.1080/15622970802465807 · Cited by 854 · cited 3×
“…a similar rigorous hierarchy of evidence and level of recommendation as was used in previous WFSBP guidelines including the first published WFSBP Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders (Bandelow et al. 2008) (see Table 2).”
MethodInfluentialSelf-citationCognitive Function at 3 Years of Age after Fetal Exposure to Antiepileptic Drugs
Meador, K. J., Baker, G. A., Browning, N., Clayton-Smith, J., Combs-Cantrell, D. T., Cohen, M., Kalayjian, L. A., Kanner, A., Liporace, J. D., Pennell, P. B., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0803531 · Cited by 812 · cited 1×
“In addition, lasting developmental delays in children of mothers who had taken valproate during pregnancy has been described (Meador et al. 2009).”
BackgroundColom, F., Vieta, E., Martínez-Arán, A., Reinares, M., Goikolea, J. M., Benabarre, A., Torrent, C., Comes, M., Corbella, B., Parramon, G., et al. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.4.402 · Cited by 791 · cited 1×
“With regards to prevention of mixed episodes, Colom et al. (2003) showed in a RCT that adjunctive psychoeducation was effective in delaying the time to a new mixed episode as defined in DSM-IV.”
BackgroundSelf-citationPacchiarotti, I., Bond, D. J., Baldessarini, R. J., Nolen, W. A., Grunze, H., Licht, R. W., Post, R. M., Berk, M., Goodwin, G. M., Sachs, G. S., et al. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.13020185 · Cited by 770 · cited 1×
“The International Society for Bipolar Disorders Task Force on antidepressants provided guidance in that regard (Pacchiarotti et al. 2013).”
BackgroundSelf-citation(1970) · Annals of Internal Medicine · doi:10.7326/0003-4819-72-6-971_2 · Cited by 705
Bowden, C. L. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.5.481 · Cited by 678 · cited 3×
“Based on a post hoc analysis of the maintenance study by Bowden et al. (2000) valproate was considered more effective than lithium as a prophylactic agent after a mixed index episode (Bowden et al. 2005), although neither medication separated from placebo.”
BackgroundMethodSelf-citationBowden, C. L. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.4.392 · Cited by 658 · cited 2×
“…of any polarity or a new manic, depressive or mixed episode Two randomised, placebo and comparator (lithium)controlled studies over 18 months demonstrated the prophylactic efficacy of lamotrigine in BD-I patients, recently (hypo)manic or depressed (Calabrese et al. 2003; Bowden et al. 2003).”
BackgroundSelf-citationClinical Course of Children and Adolescents With Bipolar Spectrum Disorders
Birmaher, B., Axelson, D., Strober, M., Gill, M. K., Valeri, S., Chiappetta, L., Ryan, N., Leonard, H., Hunt, J., Iyengar, S., et al. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.2.175 · Cited by 655 · cited 1×
“This is in line with reports that adolescent mania is more likely than adult mania to be characterised by high rates of depressive features or to be mixed (Craney and Geller 2003; Geller et al. 2004; Birmaher et al. 2006).”
Result(2017) · Lexikon des gesamten Buchwesens Online · doi:10.1163/9789004337862_lgbo_com_080023 · Cited by 645
Calabrese, J. R., Bowden, C. L., Sachs, G., Yatham, L. N., Behnke, K., Mehtonen, O.-P., Montgomery, P., Ascher, J., Paska, W., Earl, N., et al. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0906 · Cited by 635 · cited 4×
“…of any polarity or a new manic, depressive or mixed episode Two randomised, placebo and comparator (lithium)controlled studies over 18 months demonstrated the prophylactic efficacy of lamotrigine in BD-I patients, recently (hypo)manic or depressed (Calabrese et al. 2003; Bowden et al. 2003).”
BackgroundInfluentialSelf-citationOlanzapine versus placebo in the treatment of acute mania
Tohen, M., Sanger, T. M., McElroy, S. L., Tollefson, G. D., Chengappa, K. N. R., Daniel, D. G., Petty, F., Centorrino, F., Wang, R., Grundy, S. L., et al. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.5.702 · Cited by 585
Goodwin, G. M., Bowden, C. L., Calabrese, J. R., Grunze, H., Kasper, S., White, R., Greene, P., & Leadbetter, R. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0321 · Cited by 581 · cited 2×
“2003) nor a pooled analysis (Goodwin et al. 2004) supply additional separate data by medication for mixed recurrences.”
BackgroundSelf-citationTohen, M. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.9.841 · Cited by 539 · cited 1×
“The second study (Tohen et al. 2000), a 4- week RCT that recruited 115 patients (42.6% mixed) confirmed the advantage of olanzapine versus placebo on manic symptoms and response rate in both manic and mixed patients.”
BackgroundInfluentialKeck, P. E., Marcus, R., Tourkodimitris, S., Ali, M., Liebeskind, A., Saha, A., Ingenito, G., & Aripiprazole Study Group (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.9.1651 · Cited by 501
Geller, B., Tillman, R., Craney, J. L., & Bolhofner, K. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.5.459 · Cited by 475 · cited 1×
“This is in line with reports that adolescent mania is more likely than adult mania to be characterised by high rates of depressive features or to be mixed (Craney and Geller 2003; Geller et al. 2004; Birmaher et al. 2006).”
ResultTohen, M., Chengappa, K. N. R., Suppes, T., Zarate, C. A., Calabrese, J. R., Bowden, C. L., Sachs, G. S., Kupfer, D. J., Baker, R. W., Risser, R. C., et al. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.1.62 · Cited by 463 · cited 1×
“The first study, a 6-week RCT (Tohen et al. 2002), enrolled both DSM-IV manic and mixed patients (179 and 165, respectively), and compared the efficacy of olanzapine plus lithium/valproate versus placebo plus lithium/valproate.”
BackgroundSelf-citationClinical and research implications of the diagnosis of dysphoric or mixed mania or hypomania
(1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.12.1633 · Cited by 433 · cited 6×
“(according to Cincinnati Criteria (McElroy et al. 1992))”
BackgroundMethodInfluentialSachs, G. S., Grossman, F., Ghaemi, S. N., Okamoto, A., & Bowden, C. L. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.7.1146 · Cited by 424 · cited 2×
“Different from the outcome in the controlled study (Sachs et al. 2002), a 12-week, open-label study including 102 patients, but only 17 with mixed episodes, suggests efficacy for risperidone combined with lithium or valproate.”
BackgroundResultSelf-citationGrunze, H., Vieta, E., Goodwin, G. M., Bowden, C., Licht, R. W., Möller, H.-J., Kasper, S., & on behalf of the WFSBP Task Force on Treatment Guidelines for Bipolar Disorders (2013) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2013.770551 · Cited by 421 · cited 7×
“In the WFSBP guideline on long-term treatment (Grunze et al. 2013) we elaborated extensively on the definitions and timelines of continuation and prophylactic treatment, and their implications for study designs.”
BackgroundInfluentialSelf-citationGrunze, H., Vieta, E., Goodwin, G. M., Bowden, C., Licht, R. W., Möller, H.-J., Kasper, S., & WFSBP Task Force On Treatment Guidelines For Bipolar Disorders (2010) · The World Journal of Biological Psychiatry · doi:10.3109/15622970903555881 · Cited by 399 · cited 6×
“For more detailed information we refer the reader to the previous papers of this series (Grunze et al. 2009; Grunze et al. 2010; Grunze et al. 2013).”
BackgroundMethodInfluentialSelf-citationCan antidepressants cause mania and worsen the course of affective illness?
(1987) · American Journal of Psychiatry · doi:10.1176/ajp.144.11.1403 · Cited by 398 · cited 1×
“…the focus of treatment is on the regulation of mood and the correction of mood instability, however, then it becomes apparent that medication with potentially mood-destabilising effects, e.g., some antidepressants and typical antipsychotics, should be avoided (Wehr and Goodwin 1987; Akiskal 1994).”
BackgroundSubstance abuse in bipolar disorder
Cassidy, F., Ahearn, E. P., & Carroll, B. J. (2001) · Bipolar Disorders · doi:10.1034/j.1399-5618.2001.30403.x · Cited by 385 · cited 2×
“Several reports suggested a higher rate of comorbid substance abuse in mixed patients (Tohen et al. 1998; Goldberg et al. 1999; Tundo et al. 2015; McIntyre, Soczynska, et al. 2015); however, this could not be verified in all studies (Cassidy et al. 2001b).”
BackgroundDepression During Mania: Treatment Response to Lithium or Divalproex
Swann, A. C. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830130041008 · Cited by 374 · cited 8×
“2006) or did not differentiate from placebo (Swann et al. 1997).”
BackgroundInfluentialKeck, P. E., Versiani, M., Potkin, S., West, S. A., Giller, E., Ice, K., & the Ziprasidone in Mania Study Group (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.4.741 · Cited by 369
Tohen, M., Greil, W., Calabrese, J. R., Sachs, G. S., Yatham, L. N., Oerlinghausen, B. M., Koukopoulos, A., Cassano, G. B., Grunze, H., Licht, R. W., et al. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.7.1281 · Cited by 365 · cited 3×
“A re-analysis of the 1-year maintenance study of olanzapine versus lithium in recently manic or mixed patients (Tohen et al. 2005) utilising Multi-state Outcome Analysis of Treatments (MOAT) revealed that patients taking lithium spent significantly more time in mixed states than did patients taking…”
BackgroundMethodInfluentialSelf-citationMiura, T., Noma, H., Furukawa, T. A., Mitsuyasu, H., Tanaka, S., Stockton, S., Salanti, G., Motomura, K., Shimano-Katsuki, S., Leucht, S., et al. (2014) · The Lancet Psychiatry · doi:10.1016/s2215-0366(14)70314-1 · Cited by 364 · cited 1×
“Network meta-analyses, as recently conducted for acute mania (Yildiz et al. 2015), bipolar depression (Taylor et al. 2014) and bipolar maintenance (Miura et al. 2014), appear methodologically sounder and may allow a more objective ranking of drugs according to their efficacy and acceptance.”
MethodWeisler, R. H., Kalali, A. H., Ketter, T. A., & SPD417 Study Group (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0405 · Cited by 350 · cited 4×
“The first study (Weisler et al. 2004) demonstrated signifi-”
MethodResultInfluentialGrunze, H., Vieta, E., Goodwin, G. M., Bowden, C., Licht, R. W., Möller, H.-J., Kasper, S., WFSBP Task Force on Treatment Guide, Grunze, H., Vieta, E., et al. (2009) · The World Journal of Biological Psychiatry · doi:10.1080/15622970902823202 · Cited by 346 · cited 12×
“Topiramate has been tested in five RCT’s of acute mania, but failed to separate from placebo and was inferior to lithium (Grunze et al. 2009; Pigott et al. 2016).”
BackgroundMethodInfluentialSelf-citationLoebel, A., Cucchiaro, J., Silva, R., Kroger, H., Hsu, J., Sarma, K., & Sachs, G. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.13070984 · Cited by 341
Clinically Significant Pharmacokinetic Drug Interactions with Carbamazepine: An Update
Spina, E., Pisani, F., & Perucca, E. (1996) · Clinical Pharmacokinetics · doi:10.2165/00003088-199631030-00004 · Cited by 331 · cited 1×
“The use of carbamazepine can be complicated due to interaction with other psychotropic medication, including several antipsychotics, antidepressants and anticonvulsants (Spina et al. 1996), and auto-induction of its own metabolism may result in a need for constant adaption of dosage.”
BackgroundTohen, M., Chengappa, K. N. R., Suppes, T., Baker, R. W., Zarate, C. A., Bowden, C. L., Sachs, G. S., Kupfer, D. J., Ghaemi, S. N., Feldman, P. D., et al. (2004) · British Journal of Psychiatry · doi:10.1192/bjp.184.4.337 · Cited by 326 · cited 1×
“A randomised, placebo-controlled study over 18 months included patients with a manic or mixed index episode (Tohen et al. 2004).”
BackgroundSelf-citationSuppes, T., Silva, R., Cucchiaro, J., Mao, Y., Targum, S., Streicher, C., Pikalov, A., & Loebel, A. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.15060770 · Cited by 322
Goldberg, J. F., Perlis, R. H., Bowden, C. L., Thase, M. E., Miklowitz, D. J., Marangell, L. B., Calabrese, J. R., Nierenberg, A. A., & Sachs, G. S. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.08050746 · Cited by 322 · cited 2×
“Thus, the results of this (Goldberg et al. 2009) and other studies (Benazzi et al. 2004; Inoue et al. 2015) demonstrated that mixed symptoms, as well as distractibility, irritability and psychomotor agitation (which have been omitted from the DSM-5 mixed features specifier) indicate bipolarity…”
ResultSelf-citationTohen, M., Calabrese, J. R., Sachs, G. S., Banov, M. D., Detke, H. C., Risser, R., Baker, R. W., Chou, J. C.-Y., & Bowden, C. L. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.2.247 · Cited by 317 · cited 2×
“An RCT studied the efficacy of olanzapine versus placebo as monotherapy for maintenance treatment in 361 patients with a DSM-IV diagnosis of manic or mixed episodes (n1⁄4 121 mixed) (Tohen et al. 2006).”
BackgroundSelf-citationOlanzapine Versus Placebo in the Treatment of Adolescents With Bipolar Mania
Tohen, M., Kryzhanovskaya, L., Carlson, G., DelBello, M., Wozniak, J., Kowatch, R., Wagner, K., Findling, R., Lin, D., Robertson-Plouch, C., et al. (2007) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.06111932 · Cited by 315
Suicidal Behaviour in Mood Disorders—Who, When, and Why?
Isometsä, E. (2014) · The Canadian Journal of Psychiatry · doi:10.1177/070674371405900303 · Cited by 310 · cited 2×
“…of all clinical presentations of mood disorders, mixed (agitated) major depressive episode carries the highest suicide risk regardless of the whether it develops in the context of bipolar I, bipolar II, bipolar NOS or ‘unipolar’ depression (Balazs et al. 2006; Isometsa 2014; Rihmer and D€ome 2016).”
BackgroundAGITATED DEPRESSION AS A MIXED STATE AND THE PROBLEM OF MELANCHOLIA
Koukopoulos, A., & Koukopoulos, A. (1999) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(05)70095-2 · Cited by 309 · cited 1×
“Mixed state in BD-II was defined according to Koukopoulos criteria of agitated depression (Koukopoulos and Koukopoulos 1999), as prior to DSM-5 BD-II mixed states were ‘non-existent’ in classification systems).”
MethodAssessment and management of agitation in psychiatry: Expert consensus
Garriga, M., Pacchiarotti, I., Kasper, S., Zeller, S. L., Allen, M. H., Vázquez, G., Baldaçara, L., San, L., McAllister-Williams, R. H., Fountoulakis, K. N., et al. (2016) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2015.1132007 · Cited by 309 · cited 1×
“Agitation alone and its management is covered in a different report (Garriga et al. 2016).”
BackgroundSelf-citationThe comorbidity of bipolar and anxiety disorders: prevalence, psychobiology, and treatment issues
Freeman, M. P., Freeman, S. A., & McElroy, S. L. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00299-8 · Cited by 304 · cited 2×
“Subgroup analyses in mixed patients have either not been conducted/reported (Freeman et al. 2002; Bowden et al. 2006) or did not differentiate from placebo (Swann et al. 1997).”
BackgroundBalázs, J., Benazzi, F., Rihmer, Z., Rihmer, A., Akiskal, K. K., & Akiskal, H. S. (2006) · Journal of Affective Disorders · doi:10.1016/j.jad.2005.12.049 · Cited by 303 · cited 5×
“, initiation of lithium, are particularly important as, of all clinical presentations of mood disorders, mixed (agitated) major depressive episode carries the highest suicide risk regardless of the whether it develops in the context of bipolar I, bipolar II, bipolar NOS or ‘unipolar’ depression (Balazs et al. 2006; Is…”
BackgroundInfluentialA double-blind comparison of valproate and lithium in the treatment of acute mania
(1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.1.108 · Cited by 301 · cited 1×
“The study by Freeman et al. (1992) was the first controlled study that indicated that valproate was effective in the treatment of depressive symptoms that occurred concomitantly in patients with mania.”
BackgroundLoebel, A., Cucchiaro, J., Silva, R., Kroger, H., Sarma, K., Xu, J., & Calabrese, J. R. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.13070985 · Cited by 293
Keck, P. E., Calabrese, J. R., McQuade, R. D., Carson, W. H., Carlson, B. X., Rollin, L. M., Marcus, R. N., Sanchez, R., & Aripiprazole Study Group (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0414 · Cited by 290 · cited 3×
“…an acute mixed episode in preventing episodes of any polarity or a new manic, depressive or mixed episode For the 48 patients with mixed index episodes participating in the aripiprazole oral continuation studies (Keck et al. 2006; Keck et al. 2007), no separate outcome data have been reported.”
BackgroundAkiskal, H. S., Hantouche, E. G., Bourgeois, M. L., Azorin, J.-M., Sechter, D., Allilaire, J.-F., Lancrenon, S., Fraud, J.-P., & Châtenet-Duchêne, L. (1998) · Journal of Affective Disorders · doi:10.1016/s0165-0327(98)00113-x · Cited by 289 · cited 2×
“…defined bipolar disorder and bipolar spectrum disorder, have been described in the literature: greater female prevalence (Dell'Osso et al. 1991; Akiskal et al. 1998; Arnold et al. 2000), especially in mixed hypomanic patients (Suppes et al. 2005), younger age at onset and more recurrences…”
BackgroundSelf-citationCalabrese, J. R., Shelton, M. D., Rapport, D. J., Youngstrom, E. A., Jackson, K., Bilali, S., Ganocy, S. J., & Findling, R. L. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.11.2152 · Cited by 252 · cited 1×
“…a 20-month maintenance RCT comparing valproate and lithium in recently manic rapid cycling patients who were initially stabilised on combined treatment with lithium and valproate (Calabrese et al. 2005), no statistical difference emerged between valproate and lithium in preventing a mixed episode.”
BackgroundSachs, G., Sanchez, R., Marcus, R., Stock, E., Mcquade, R., Carson, W., Abou-Gharbia, N., Impellizzeri, C., Kaplita, S., Rollin, L., et al. (2006) · Journal of Psychopharmacology · doi:10.1177/0269881106059693 · Cited by 251 · cited 1×
“In DSM-IV mixed episode patients, aripiprazole produced significantly greater improvements from baseline compared with placebo in YMRS total score (P¼ 0.01), and significantly greater improvements from baseline in MADRS total score compared with placebo at endpoint (P¼ 0.04) (Sachs et al. 2006).”
ResultInfluentialHyponatremia Associated with Carbamazepine and Oxcarbazepine Therapy: A Review
Van Amelsvoort, T., Bakshi, R., Devaux, C. B., & Schwabe, S. (1994) · Epilepsia · doi:10.1111/j.1528-1157.1994.tb02930.x · Cited by 250 · cited 1×
“However, oxcarbazepine also has an interaction potential with other medication, and the risk of hyponatremia might be higher than with carbamazepine (Van Amelsvoort et al. 1994).”
BackgroundYatham, L. N., Grossman, F., Augustyns, I., Vieta, E., & Ravindran, A. (2003) · British Journal of Psychiatry · doi:10.1192/bjp.182.2.141 · Cited by 248 · cited 2×
“The mean reductions in depressive symptoms scores were significantly reduced at week 3 (P< 0.03) but not at week 12 in mixed patients (Yatham et al. 2003).”
BackgroundInfluentialSelf-citationA History of Substance Abuse Complicates Remission From Acute Mania in Bipolar Disorder
Goldberg, J. F., Garno, J. L., Leon, A. C., Kocsis, J. H., & Portera, L. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n1103 · Cited by 238 · cited 2×
“Several reports suggested a higher rate of comorbid substance abuse in mixed patients (Tohen et al. 1998; Goldberg et al. 1999; Tundo et al. 2015; McIntyre, Soczynska, et al. 2015); however, this could not be verified in all studies (Cassidy et al.”
BackgroundKeck, P. E., & Calabrese, J. R. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n1003 · Cited by 238 · cited 3×
“…an acute mixed episode in preventing episodes of any polarity or a new manic, depressive or mixed episode For the 48 patients with mixed index episodes participating in the aripiprazole oral continuation studies (Keck et al. 2006; Keck et al. 2007), no separate outcome data have been reported.”
BackgroundRisperidone Treatment for Juvenile Bipolar Disorder: A Retrospective Chart Review
FRAZIER, J. A., MEYER, M. C., BIEDERMAN, J., WOZNIAK, J., WILENS, T. E., SPENCER, T. J., KIM, G. S., & SHAPIRO, S. (1999) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199908000-00011 · Cited by 237 · cited 1×
“A retrospective chart review looking at 28 children and adolescents with DSM-IV bipolar disorder (25 mixed and three hypomanic) supports efficacy of risperidone in reducing manic and psychotic symptoms (Frazier et al. 1999).”
BackgroundSuppes, T., Vieta, E., Liu, S., Brecher, M., Paulsson, B., & Trial 127 Investigators (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.08020189 · Cited by 230 · cited 1×
“We found two identically designed RCTs that studied maintenance treatment in mixed, manic, or depressive bipolar patients, and compared the efficacy of quetiapine þ lithium or valproate versus placebo þ lithium or valproate (Vieta, Suppes, et al. 2008; Suppes et al. 2009).”
ResultSelf-citationA 12-Week, Double-blind Comparison of Olanzapine vs Haloperidol in the Treatment of Acute Mania
Tohen, M., Goldberg, J. F., Gonzalez-Pinto Arrillaga, A. M., Azorin, J. M., Vieta, E., Hardy-Bayle, M.-C., Lawson, W. B., Emsley, R. A., Zhang, F., Baker, R. W., et al. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.12.1218 · Cited by 229
Self-citationVieta, E., Suppes, T., Eggens, I., Persson, I., Paulsson, B., & Brecher, M. (2008) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.06.001 · Cited by 227
Self-citationSwann, A. C., Lafer, B., Perugi, G., Frye, M. A., Bauer, M., Bahk, W.-M., Scott, J., Ha, K., & Suppes, T. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12030301 · Cited by 217 · cited 1×
“A major problem for including mixed states in studies is the lack of a generally accepted definition (Gonz alez-Pinto et al. 2003; Cassidy et al. 2008; Vieta and Morralla 2010; Swann et al. 2013).”
BackgroundSuppes, T., Mintz, J., McElroy, S. L., Altshuler, L. L., Kupka, R. W., Frye, M. A., Keck, P. E., Nolen, W. A., Leverich, G. S., Grunze, H., et al. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.10.1089 · Cited by 209 · cited 2×
“2000), especially in mixed hypomanic patients (Suppes et al. 2005), younger age at onset and more recurrences during follow-up (Gonz alez-Pinto et al.”
BackgroundSelf-citationDurgam, S., Earley, W., Lipschitz, A., Guo, H., Laszlovszky, I., Németh, G., Vieta, E., Calabrese, J. R., & Yatham, L. N. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.15020164 · Cited by 209 · cited 1×
“The reported figures for akathisia range from 4.8% (for 1.5mg in bipolar depression) to approximately 25% with dosages up to 12mg in the acute mania studies (Citrome 2013; Durgam et al. 2016; Earley et al. 2017).”
BackgroundInfluentialSelf-citationDifferential Response to Lithium and Carbamazepine in the Prophylaxis of Bipolar Disorder
Greil, W., Kleindienst Nikolaus, D.-S., Erazo Natalia, D.-P., & Muller-Oerlinghausen, B. (1998) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199812000-00007 · Cited by 206 · cited 1×
“Whereas in ‘classical’ BD-I patients lithium was significantly better than carbamazepine in preventing hospitalisation (P¼ 0.031); see Figure 1) there was the tendency in favour of carbamazepine in the mixed group (Greil et al. 1998).”
ResultInfluentialSuicidality in patients with pure and depressive mania
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.9.1312 · Cited by 201 · cited 4×
“2011), more frequent prior suicide attempts (Dilsaver et al. 1994; Strakowski et al. 1996; Goldberg et al. 1998), longer and more expensive hospitalisations (Gonz alez-Pinto et al.”
BackgroundInfluentialPerugi, G., Micheli, C., Akiskal, H. S., Madaro, D., Socci, C., Quilici, C., & Musetti, L. (2000) · Comprehensive Psychiatry · doi:10.1016/s0010-440x(00)90125-1 · Cited by 200
Use of topiramate, a new anti-epileptic as a mood stabilizer
Marcotte, D. (1998) · Journal of Affective Disorders · doi:10.1016/s0165-0327(98)00110-4 · Cited by 197 · cited 2×
“(Marcotte 1998).”
BackgroundBipolar I: A Five-Year Prospective Follow-up
KELLER, M. B., LAVORI, P. W., CORYELL, W., ENDICOTT, J., & MUELLER, T. I. (1993) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199304000-00005 · Cited by 196 · cited 1×
“Observational maintenance studies with lithium also indicate that patients with an index episode of mixed mania were less likely to recover with long-term lithium treatment than were patients with an index episode of elated mania or bipolar depression (Keller et al. 1993).”
BackgroundVieta, E., Durgam, S., Lu, K., Ruth, A., Debelle, M., & Zukin, S. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.08.020 · Cited by 191
Self-citationMcIntyre, R. S., Cohen, M., Zhao, J., Alphs, L., Macek, T. A., & Panagides, J. (2009) · Bipolar Disorders · doi:10.1111/j.1399-5618.2009.00748.x · Cited by 189 · cited 12×
“Both acute studies (McIntyre et al. 2009; McIntyre et al. 2010a) also captured changes of”
BackgroundMethodInfluentialTolerability of paliperidone: a meta-analysis of randomized, controlled trials
Harrington, C. A., & English, C. (2010) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e32833db3d8 · Cited by 189 · cited 2×
“A meta-analysis including 15 studies with paliperidone, mostly in schizophrenia, found as adverse events with the greatest incidence extrapyramidal symptoms (23%), headache (14%), insomnia (11%), somnolence (9%), tachycardia (9%) and weight gain (8%) (Harrington and English 2010).”
Signs and symptoms of mania in pure and mixed episodes
Cassidy, F., Murry, E., Forest, K., & Carroll, B. J. (1998) · Journal of Affective Disorders · doi:10.1016/s0165-0327(98)00016-0 · Cited by 188 · cited 2×
“In their review of early studies (between 1971 and 1990) in mixed states, Cassidy et al. (1998) identified the following signs and symptoms possibly relevant to mixed manic states based on selected studies: depressed mood, anxiety, lability, paranoia, hostility and psychosis.”
BackgroundMethodRisperidone in the treatment of acute mania: Double-blind, placebo-controlled study
Khanna, S., Vieta, E., Lyons, B., Grossman, F., Eerdekens, M., & Kramer, M. (2005) · British Journal of Psychiatry · doi:10.1192/bjp.187.3.229 · Cited by 188 · cited 2×
“The only risperidone monotherapy trial including mixed patients did not show improvement of manic symptoms versus placebo (Khanna et al. 2005).”
BackgroundSelf-citationErnst, C. L., & Goldberg, J. F. (2002) · PubMed · Cited by 181
DSM‐5 criteria for depression with mixed features: a farewell to mixed depression
Koukopoulos, A., & Sani, G. (2014) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12140 · Cited by 181 · cited 1×
“This was clearly demonstrated by the late Kokoupoulos and colleague (Koukopoulos and Sani 2014) in a comprehensive review.”
BackgroundClassification of Endogenous Psychoses and their Differentiated Etiology
Leonhard, K. (1999) · Springer eBooks · doi:10.1007/978-3-7091-6371-9 · Cited by 176 · cited 1×
“Cycloid psychoses, because of their polymorphous and bipolar traits, might resemble a true bipolar mixed state (Leonhard 1999).”
BackgroundMixed Features in Patients With a Major Depressive Episode: the BRIDGE-II-MIX Study
Perugi, G., Angst, J., Azorin, J.-M., Bowden, C. L., Mosolov, S., Reis, J., Vieta, E., & Young, A. H. (2015) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14m09092 · Cited by 175 · cited 2×
“Of note, neither distractibility nor psychomotor agitation define a major depressive episode with mixed features (Malhi et al. 2014; Perugi et al. 2015).”
BackgroundSelf-citationPerugi, G., Akiskal, H. S., Micheli, C., Toni, C., & Madaro, D. (2001) · Journal of Affective Disorders · doi:10.1016/s0165-0327(01)00443-8 · Cited by 175 · cited 1×
“…et al. 2011; Mazzarini et al. 2017), more past mixed episodes (Wilhelm et al. 2007), higher probability of mixed episodes at illness onset (Perugi et al. 2001), more irritability (Swann 2000), aggressiveness (Verdolini et al. 2017), suicidality (Dilsaver et al. 1994; Strakowski et al.…”
BackgroundSchaffer, A., Isometsä, E. T., Tondo, L., Moreno, D. H., Sinyor, M., Kessing, L. V., Turecki, G., Weizman, A., Azorin, J.-M., Ha, K., et al. (2015) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867415594427 · Cited by 175 · cited 1×
“Lithium may exert a protective effect across the diagnostic spectrum in BD (Schaffer et al. 2015; Popovic et al. 2015).”
BackgroundSelf-citationVieta, E., Bourin, M., Sanchez, R., Marcus, R., Stock, E., McQuade, R., Carson, W., Abou-Gharbia, N., Swanink, R., & Iwamoto, T. (2005) · British Journal of Psychiatry · doi:10.1192/bjp.187.3.235 · Cited by 173 · cited 1×
“A randomised, double-blind comparison of aripiprazole against haloperidol was also underpowered for a separate analysis of mixed patients (Vieta et al. 2005).”
ResultSelf-citationKeck, P. E., Orsulak, P. J., Cutler, A. J., Sanchez, R., Torbeyns, A., Marcus, R. N., McQuade, R. D., & Carson, W. H. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.05.014 · Cited by 172
Weisler, R. H., Nolen, W. A., Neijber, A., Hellqvist, Å., Paulsson, B., & Trial 144 Study Investigators (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.11m06878 · Cited by 169 · cited 2×
“Patients with a mixed index episode had a significantly lower risk of a relapse into a new manic episode (HR (95% CI) 0.34 (0.12–0.95)) and episode of any type compared to placebo (HR (95% CI) 0.48 (0.27–0.86))(Weisler et al. 2011; Nolen and Weisler 2013).”
BackgroundInfluentialLithium: Still a Major Option in the Management of Bipolar Disorder
Licht, R. W. (2012) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2011.00260.x · Cited by 168 · cited 1×
“From the patient perspective, in addition to the above-mentioned adverse effects, the risk of weight gain and the risk of mental side effects (cognitive impairment and/or reduced intensity of perceptions and emotions) may be most crucial (Licht 2011).”
BackgroundSelf-citationSuicidality among patients with mixed and manic bipolar disorder
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.5.674 · Cited by 167 · cited 5×
“2011), more frequent prior suicide attempts (Dilsaver et al. 1994; Strakowski et al. 1996; Goldberg et al. 1998), longer and more expensive hospitalisations (Gonz alez-Pinto et al.”
BackgroundInfluentialSources of lithium resistance in mixed mania.
Himmelhoch, J. M., & Garfinkel, M. E. (1986) · PubMed · Cited by 165
The Effect of Comorbid Substance Use Disorders on the Course of Bipolar Disorder: A Review
Tohen, M., Greenfield, S. F., Weiss, R. D., Zarate, C. A., & Vagge, L. M. (1998) · Harvard Review of Psychiatry · doi:10.3109/10673229809000321 · Cited by 163 · cited 2×
“Several reports suggested a higher rate of comorbid substance abuse in mixed patients (Tohen et al. 1998; Goldberg et al. 1999; Tundo et al. 2015; McIntyre, Soczynska, et al. 2015); however, this could not be verified in all studies (Cassidy et al.”
BackgroundWeisler, R. H., Keck, P. E., Swann, A. C., Cutler, A. J., Ketter, T. A., Kalali, A. H., & SPD417 Study Group (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0308 · Cited by 162 · cited 4×
“(N1⁄4 62) mixed, 33% (N1⁄4 30) manic) who had participated previously in the two 3-week, double-blind, placebo-controlled studies (Weisler et al. 2004; Weisler et al. 2005).”
BackgroundMethodInfluentialMcIntyre, R. S., Cohen, M., Zhao, J., Alphs, L., Macek, T. A., & Panagides, J. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.12.028 · Cited by 162 · cited 8×
“Both acute studies (McIntyre et al. 2009; McIntyre et al. 2010a) also captured changes of depressive symptomatology finding significant superiority versus placebo for olanzapine, but not for asenapine.”
BackgroundMethodInfluentialVieta, E., T’joen, C., McQuade, R. D., Carson, W. H., Marcus, R. N., Sanchez, R., Owen, R., & Nameche, L. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.07101560 · Cited by 161
Self-citationPotkin, S. G., Keck, P. E., Segal, S., Ice, K., & English, P. (2005) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000169068.34322.70 · Cited by 159 · cited 1×
“The replication trial by Potkin et al. (2005) included 83 mixed patients, but did not report a separate subgroup analysis.”
MethodShock therapy: a history of electroconvulsive treatment in mental illness
(2008) · Choice Reviews Online · doi:10.5860/choice.45-4420 · Cited by 157
Prien, R. F., Himmelhoch, J. M., & Kupfer, D. J. (1988) · Journal of Affective Disorders · doi:10.1016/0165-0327(88)90003-1 · Cited by 157 · cited 3×
“On the other end of the range, Prien et al. (1988), in their NIMH collaborative study, found that 67% of admitted manic patients fulfilled mixed episode criteria as defined by the authors.”
BackgroundInfluentialDysphoric Mania: Clinical and Biological Correlates
Post, R. M. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810040059009 · Cited by 157 · cited 1×
“A retrospective chart analyses in 22 RDC/DSM-III manic patients by Post et al. (1989) supplied the first evidence that carbamazepine might be a preferred treatment in mixed patients.”
BackgroundKessing, L. V., Gerds, T. A., Feldt-Rasmussen, B., Andersen, P. K., & Licht, R. W. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.1834 · Cited by 156 · cited 1×
“Long-term lithium treatment affects kidney function (Tredget et al. 2010; Kessing et al. 2015), and close monitoring of the eGRF is essential part of lithium safety measures (Jefferson 2010).”
BackgroundSelf-citationTopiramate as add‐on treatment for patients with bipolar mania
Roy Chengappa, K., Rathore, D., Levine, J., Atzert, R., Solai, L., Parepally, H., Levin, H., Moffa, N., Delaney, J., & Brar, J. S. (1999) · Bipolar Disorders · doi:10.1034/j.1399-5618.1999.10111.x · Cited by 153 · cited 1×
“The open-label study by Chengappa et al. (1999) also included patients resistant to mood stabiliser or antipsychotic treatment; out of the five mixed patients included, three (60”
MethodLithium-associated clinical hypothyroidism: Prevalence and risk factors
Johnston, A. M., & Eagles, J. M. (1999) · British Journal of Psychiatry · doi:10.1192/bjp.175.4.336 · Cited by 153
Guidelines for the recognition and management of mixed depression
Stahl, S. M., Morrissette, D. A., Faedda, G., Fava, M., Goldberg, J. F., Keck, P. E., Lee, Y., Malhi, G., Marangoni, C., McElroy, S. L., et al. (2017) · CNS Spectrums · doi:10.1017/s1092852917000165 · Cited by 152 · cited 1×
“Instead, we would like to refer the reader to a recent expert guidance on depressive mixed states (Stahl et al. 2017).”
BackgroundSelf-citationMixed states in DSM-5: Implications for clinical care, education, and research
Vieta, E., & Valentí, M. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.03.007 · Cited by 146 · cited 2×
“…problems: for example, anxiety, irritability, aggressiveness and agitation, the most common and pronounced symptoms of mixed states (Tohen, Calabrese, et al. 2007; Verdolini et al. 2017), are not included in the concept because of lack of specificity (Vieta and Valenti 2013; Perugi et al. 2015).”
BackgroundSelf-citationBowden, C. L., Vieta, E., Ice, K. S., Schwartz, J. H., Wang, P. P., & Versavel, M. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09m05482yel · Cited by 144
Self-citationBowden, C. L., Swann, A. C., Calabrese, J. R., Rubenfaer, L. M., Wozniak, P. J., Collins, M. A., Abi-Saab, W., Saltarelli, M., & Depakote ER Mania Study Group (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n1003 · Cited by 142 · cited 3×
“Subgroup analyses in mixed patients have either not been conducted/reported (Freeman et al. 2002; Bowden et al. 2006) or did not differentiate from placebo (Swann et al. 1997).”
BackgroundSelf-citationMelancholia agitata and mixed depression
Koukopoulos, A., Sani, G., Koukopoulos, A. E., Manfredi, G., Pacchiarotti, I., & Girardi, P. (2007) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2007.00963.x · Cited by 141 · cited 2×
“To illustrate further Kraepelin’s holistic approach towards affective disorders, a diminished speed of thinking or negative thoughts, low mood but increased agitation would characterise what he defined as ‘depressive Erregung’ (depressive excitement), an affective state that today sometimes is labelled ‘agitated depre…”
BackgroundEffects of chronic lithium treatment on renal function
Tredget, J., Kirov, A., & Kirov, G. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.04.018 · Cited by 140 · cited 1×
“Long-term lithium treatment affects kidney function (Tredget et al. 2010; Kessing et al. 2015), and close monitoring of the eGRF is essential part of lithium safety measures (Jefferson 2010).”
BackgroundPattern of Response to Divalproex, Lithium, or Placebo in Four Naturalistic Subtypes of Mania
Swann, A. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00390-6 · Cited by 137 · cited 3×
“Manic episodes with or without subsyndromal depression also differ in treatment response (Swann et al. 1997; Swann et al. 2002), severity of anxiety (Swann et al.”
BackgroundCalabrese, J. R., Sanchez, R., Jin, N., Amatniek, J., Cox, K., Johnson, B., Perry, P., Hertel, P., Such, P., Salzman, P. M., et al. (2017) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.16m11201 · Cited by 135
Nasrallah, H. A., & Newcomer, J. W. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000142282.62336.e9 · Cited by 132 · cited 1×
“For detailed information we refer the reader to the respective publications (Nasrallah and Newcomer 2004).”
BackgroundBenazzi, F., Koukopoulos, A., & Akiskal, H. S. (2004) · European Psychiatry · doi:10.1016/j.eurpsy.2003.09.008 · Cited by 132 · cited 6×
“Akiskal and Benazzi later aimed to verify the existence of distinct subtypes of mixed depression, an ‘excited depression’ subtype (defined by the core feature of psychomotor agitation, and further characterised by talkativeness, irritable mood and distractibility) and a ‘depression with flight of ideas’ subtype (defin…”
BackgroundResultInfluentialDurgam, S., Starace, A., Li, D., Migliore, R., Ruth, A., Németh, G., & Laszlovszky, I. (2015) · Bipolar Disorders · doi:10.1111/bdi.12238 · Cited by 130 · cited 2×
“…studies investigated the efficacy of cariprazine monotherapy in DSM-IV manic and mixed BD-I patients (Calabrese et al. 2015; Sachs et al. 2015; Durgam et al. 2015) that were also subject to a pooled analysis (Vieta et al. Mixed episode Manic mixed episode RG 2: olanzapine, olanzapine +…”
MethodMarcus, R., Khan, A., Rollin, L., Morris, B., Timko, K., Carson, W., & Sanchez, R. (2011) · Bipolar Disorders · doi:10.1111/j.1399-5618.2011.00898.x · Cited by 130 · cited 2×
“…hoc analysis of a 52-week maintenance combination study (aripiprazoleþ lithium or valproate versus placeboþ lithium or valproate), in 107 patients with DSM-IV mixed mania at entry but stabilised at baseline (ClinicalTrials.gov Identifier: NCT00261443, original publication (Marcus et al. 2011)).”
BackgroundTohen, M., McDonnell, D. P., Case, M., Kanba, S., Ha, K., Fang, Y. R., Katagiri, H., & Gomez, J.-C. (2012) · British Journal of Psychiatry · doi:10.1192/bjp.bp.112.108357 · Cited by 128 · cited 1×
“This study, together with a second study in Japanese patients with bipolar depression (Tohen et al. 2012) was also subject to a pooled analysis (Tohen, Kanba, et al. 2014).”
ResultYildiz, A., Nikodem, M., Vieta, E., Correll, C. U., & Baldessarini, R. J. (2015) · Psychological Medicine · doi:10.1017/s0033291714001305 · Cited by 128 · cited 2×
“Network meta-analyses, as recently conducted for acute mania (Yildiz et al. 2015), bipolar depression (Taylor et al. 2014) and bipolar maintenance (Miura et al. 2014), appear methodologically sounder and may allow a more objective ranking of drugs according to their efficacy and acceptance.”
MethodSelf-citationSachs, G. S., Greenberg, W. M., Starace, A., Lu, K., Ruth, A., Laszlovszky, I., Németh, G., & Durgam, S. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.11.018 · Cited by 127 · cited 2×
“Of the phase III studies, none does supply any information (size, outcomes) about the mixed subgroup (Calabrese et al. 2015; Sachs et al. 2015), nor does the first pooled analysis of all studies.”
BackgroundMethodSafety of Haloperidol and Penfluridol in Pregnancy: A Multicenter, Prospective, Controlled Study
Diav-Citrin, O., Shechtman, S., Ornoy, S., Arnon, J., Schaefer, C., Garbis, H., Clementi, M., & Ornoy, A. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0307 · Cited by 127 · cited 1×
“Haloperidol is generally considered as a relatively safe option (Diav-Citrin et al. 2005).”
BackgroundMcIntyre, R. S., Soczynska, J. K., Cha, D. S., Woldeyohannes, H. O., Dale, R. S., Alsuwaidan, M. T., Gallaugher, L. A., Mansur, R. B., Muzina, D. J., Carvalho, A. F., et al. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.09.026 · Cited by 126
Craney, J. L., & Geller, B. (2003) · Bipolar Disorders · doi:10.1034/j.1399-5618.2003.00044.x · Cited by 125 · cited 1×
“This is in line with reports that adolescent mania is more likely than adult mania to be characterised by high rates of depressive features or to be mixed (Craney and Geller 2003; Geller et al. 2004; Birmaher et al. 2006).”
ResultClinical Predictors of Acute Response With Quetiapine in Psychotic Mood Disorders
Zarate, C. A., Rothschild, A., Fletcher, K. E., Madrid, A., & Zapatel, J. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n0307 · Cited by 124 · cited 1×
“A retrospective study of patients with bipolar disorder and other bipolar spectrum disorders, reported that the proportion of mixed patients responding to quetiapine was 77% (Zarate et al. 2000).”
BackgroundClozapine in the treatment of dysphoric mania
Suppes, T. M., McElroy, S. L., Gilbert, J. M., Dessain, E. C., & Cole, J. O. (1992) · Biological Psychiatry · doi:10.1016/0006-3223(92)90108-c · Cited by 123 · cited 1×
“All seven patients improved significantly in both their psychotic and affective symptoms (Suppes et al. 1992).”
BackgroundVieta, E., Nuamah, I. F., Lim, P., Yuen, E. C., Palumbo, J. M., Hough, D. W., & Berwaerts, J. (2010) · Bipolar Disorders · doi:10.1111/j.1399-5618.2010.00815.x · Cited by 122 · cited 2×
“Three weeks of ER-paliperidone was superior to placebo in manic symptom reductions, and was non-inferior to quetiapine at 9-weeks follow-up, an effect not due to the baseline diagnosis of mixed or manic episode (P¼ 0.3) (Vieta et al. 2010).”
BackgroundResultInfluentialSelf-citationOrigin and development of concepts of bipolar mixed states
Marneros, A. (2001) · Journal of Affective Disorders · doi:10.1016/s0165-0327(01)00437-2 · Cited by 122 · cited 2×
“As with the previous guidelines, we did not include schizoaffective disorders per se despite their wide similarities with bipolar disorder (Marneros 2001b) as it was felt that such a broad spectrum view would go beyond the scope of this paper.”
BackgroundResultTaylor, D. M., Cornelius, V., Smith, L., & Young, A. H. (2014) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12343 · Cited by 122 · cited 1×
“Network meta-analyses, as recently conducted for acute mania (Yildiz et al. 2015), bipolar depression (Taylor et al. 2014) and bipolar maintenance (Miura et al. 2014), appear methodologically sounder and may allow a more objective ranking of drugs according to their efficacy and acceptance.”
MethodCalabrese, J. R., Keck, Jr., Starace, A., Lu, K., Ruth, A., Laszlovszky, I., Németh, G., & Durgam, S. (2015) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14m09081 · Cited by 121 · cited 2×
“Three double-blind, placebo-controlled studies investigated the efficacy of cariprazine monotherapy in DSM-IV manic and mixed BD-I patients (Calabrese et al. 2015; Sachs et al. 2015; Durgam et al. 2015) that were also subject to a pooled analysis (Vieta et al. Mixed episode Manic mixed episode RG…”
BackgroundMethodFirst‐episode types in bipolar disorder: predictive associations with later illness
Baldessarini, R. J., Tondo, L., & Visioli, C. (2014) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12204 · Cited by 121 · cited 1×
“Other studies report on even higher gender ratios to the disadvantage of women (e.g., Baldessarini et al. 2014).”
BackgroundAssociation of Recurrent Suicidal Ideation With Nonremission From Acute Mixed Mania
Goldberg, J. F., Garno, J. L., Leon, A. C., Kocsis, J. H., & Portera, L. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.12.1753 · Cited by 114 · cited 2×
“2011), more frequent prior suicide attempts (Dilsaver et al. 1994; Strakowski et al. 1996; Goldberg et al. 1998), longer and more expensive hospitalisations (Gonz alez-Pinto et al.”
BackgroundAsenapine for long-term treatment of bipolar disorder: A double-blind 40-week extension study
McIntyre, R. S., Cohen, M., Zhao, J., Alphs, L. D., Macek, T. A., & Panagides, J. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.04.005 · Cited by 110 · cited 8×
“Both acute studies (McIntyre et al. 2009; McIntyre et al. 2010a) also captured changes of depressive symptomatology finding significant superiority versus placebo for olanzapine, but not for asenapine.”
BackgroundMethodInfluentialDell’Osso, L., Placidi, G. F., Nassi, R., Freer, P., Cassano, G. B., & Akiskal, H. S. (1991) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf02189532 · Cited by 109 · cited 1×
“Several distinctive features and predictors of mixed episodes, in both narrowly defined bipolar disorder and bipolar spectrum disorder, have been described in the literature: greater female prevalence (Dell'Osso et al. 1991; Akiskal et al. 1998; Arnold et al. 2000), especially in mixed hypomanic patients (Suppes et al.”
BackgroundClozapine in Adolescent Inpatients with Acute Mania
Masi, G., Mucci, M., & Millepiedi, S. (2002) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/104454602760219135 · Cited by 109 · cited 1×
“With clozapine alone or in combination with mood stabilisers, all patients (five pure manic, five mixed) were considered responders, and with significant improvements in manic and depressive outcomes (all P values <0.001) (Masi et al. 2002).”
BackgroundInfluentialYoung, A. H., Oren, D. A., Lowy, A., McQuade, R. D., Marcus, R. N., Carson, W. H., Spiller, N. H., Torbeyns, A. F., & Sanchez, R. (2009) · British Journal of Psychiatry · doi:10.1192/bjp.bp.108.049965 · Cited by 109 · cited 1×
“No separate outcome analyses have been published for further RCTs including manic and DSM-IV mixed patients, namely the positive studies by Young et al. (2009), Keck, Orsulak, et al. (2009) and Zimbroff et al. (2007), and the negative acute study by ElMallakh et al. (2010) despite including…”
BackgroundCiapparelli, A., Dell'Osso, L., Tundo, A., Pini, S., Chiavacci, M. C., Di Sacco, I., & Cassano, G. B. (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n07a09 · Cited by 107 · cited 1×
“Ciapparelli et al. (2001) did not find any difference between treatment-resistant bipolar patients with depression (n¼ 23) and mixed manic episodes (n¼ 41) in terms of number of ECT sessions needed, but reported a higher response rate of 56% for mixed mania compared to 26% for bipolar depression.”
Management of Acute Agitation in Patients With Bipolar Disorder
ZIMBROFF, D. L., Marcus, R. N., Manos, G., Stock, E. G., McQuade, R. D., Auby, P., & Oren, D. A. (2007) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b13e318033bd5e · Cited by 105 · cited 1×
“…been published for further RCTs including manic and DSM-IV mixed patients, namely the positive studies by Young et al. (2009), Keck, Orsulak, et al. (2009) and Zimbroff et al. (2007), and the negative acute study by ElMallakh et al. (2010) despite including reasonable numbers of mixed patients.”
BackgroundKessing, L. V., Hellmund, G., Geddes, J. R., Goodwin, G. M., & Andersen, P. K. (2011) · British Journal of Psychiatry · doi:10.1192/bjp.bp.110.084822 · Cited by 105
Self-citationSuicide attempts in major depressive episode: evidence from the BRIDGE‐II‐Mix study
Popovic, D., Vieta, E., Azorin, J., Angst, J., Bowden, C. L., Mosolov, S., Young, A. H., & Perugi, G. (2015) · Bipolar Disorders · doi:10.1111/bdi.12338 · Cited by 103 · cited 1×
“Lithium may exert a protective effect across the diagnostic spectrum in BD (Schaffer et al. 2015; Popovic et al. 2015).”
BackgroundSelf-citationBerwaerts, J., Melkote, R., Nuamah, I., & Lim, P. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.01.047 · Cited by 101
Using Science to Improve the Nation's Health System
Lauer, M. S., & Collins, F. S. (2010) · JAMA · doi:10.1001/jama.2010.726 · Cited by 101 · cited 1×
“Following the logic of the recent BAP Guideline (Goodwin et al. 2016), the recent commitment of the NIH to prioritize effectiveness studies (Lauer and Collins 2010), and based on the quantity and quality of the data, and reliability of the source, it was finally decided to attribute the study of…”
MethodA Pilot Trial of Adjunctive Gabapentin in the Treatment of Bipolar Disorder
McElroy, S. L., Soutullo, C. A., Keck, P. E., & Kmetz, G. F. (1997) · Annals of Clinical Psychiatry · doi:10.1023/a:1026257303275 · Cited by 99 · cited 1×
“In one of them, eight of nine Bipolar I or II patients with mixed symptoms inadequately responsive to mood stabilisers, improved in their manic symptoms in the short term (1–3 months), and maintained response (1–7 months) (McElroy et al. 1997).”
BackgroundRonald Bottlender, A., Sato, T., Kleindienst, N., Strauß, A., & Möller, H. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(02)00265-3 · Cited by 99 · cited 1×
“Current evidence from prospective or retrospective studies support the notion that mixed patients are at higher risk for a maniform switch (Bottlender et al. 2004; Strejilevich et al. 2011; Valenti et al. 2011; Inoue et al. 2015; Barbuti et al. 2017).”
BackgroundSelf-citationTHE DISTINCTIVE MIXED STATES OF BIPOLAR I, II, AND III
Akiskal, H. S. (1992) · Clinical Neuropharmacology · doi:10.1097/00002826-199201001-00327 · Cited by 98 · cited 1×
“He proposed a model explaining mixed episodes as states arising when an affective episode and temperament are of opposite polarities (e.g., a manic phase in a subject with a depressive temperament or a melancholic phase in a subject with a hyperthymic temperament) (Akiskal 1992).”
BackgroundMania and depression. Mixed, not stirred
Pacchiarotti, I., Mazzarini, L., Kotzalidis, G. D., Valentí, M., Nivoli, A., Sani, G., Torrent, C., Murru, A., Sánchez‐Moreno, J., Patrizi, B., et al. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.03.037 · Cited by 97 · cited 1×
“Manic episodes with or without subsyndromal depression also differ in treatment response (Swann et al. 1997; Swann et al. 2002), severity of anxiety (Swann et al. 1986; Swann et al. 2002) and duration (Pacchiarotti et al. 2011).”
BackgroundSelf-citation(1983) · American Journal of Psychiatry · doi:10.1176/ajp.140.9.1127 · Cited by 97 · cited 1×
“In 1854, the French psychiatrist Falret described ‘transitional states’ that emerged during the switch from mania to depression and depression to mania (Falret 1854; Sedler 1983; Pichot 2004).”
BackgroundPerlis, R. H., Baker, R. W., Zarate, C. A., Brown, E. B., Schuh, L. M., Jamal, H. H., & Tohen, M. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n1112 · Cited by 95 · cited 2×
“Another RCT compared the efficacy of olanzapine versus risperidone in manic/mixed patients, and reported no significant differences in manic and depressive improvement, or rates of response or remission between treatments in either manic or mixed patients (Perlis et al. 2006).”
BackgroundResultBipolar disorders following initial depression: Modeling predictive clinical factors
Tondo, L., Visioli, C., Preti, A., & Baldessarini, R. J. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.05.043 · Cited by 94 · cited 2×
“…been well acknowledged for long time and is logically evident, that theoretically all ‘unipolar’ (more precisely ‘nonbipolar’) episodes of major depression could be part of bipolar disorder due to the well-known and not uncommon unipolar-bipolar conversion (Tondo et al. 2014; James et al. 2015).”
BackgroundBerwaerts, J., Lane, R., Nuamah, I. F., Lim, P., Remmerie, B. M. M., & Hough, D. W. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.09.011 · Cited by 92 · cited 1×
“However, in a further RCT patients with a mixed index episode had no benefit from paliperidone treatment in combination with lithium or valproate (Berwaerts et al. 2011).”
BackgroundThe Efficacy of ECT in Mixed Affective States
Devanand, D. P., Polanco, P., Cruz, R., Shah, S., Paykina, N., Singh, K., & Majors, L. (2000) · The Journal of ECT · doi:10.1097/00124509-200003000-00004 · Cited by 91 · cited 1×
“Other studies (Devanand et al. 2000) that compared the response to ECT in mixed state, bipolar depression, and mania, showed robust response rates in all groups: 80% in the mixed group, 100% in the manic group, and 76% in the depressed group.”
ResultGonzález-Pinto, A. M. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(02)00070-8 · Cited by 91
Szegedi, A., Calabrese, J. R., Stet, L., Mackle, M., Zhao, J., & Panagides, J. (2012) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31823f872f · Cited by 89 · cited 7×
“Again, both extension studies (McIntyre et al. 2010b; Szegedi et al. 2012) did not supply separate data for mixed relapses after a manic index episode.”
BackgroundInfluentialMaintenance ECT in intractable manic-depressive disorders.
Vanelle, J. M., Lôo, H., Galinowski, A., de Carvalho, W., Bourdel, M., Brochier, P., Bouvet, O., Brochier, T., & Olié, J. (1994) · PubMed · Cited by 87
Tohen, M., Vieta, E., Goodwin, G. M., Sun, B., Amsterdam, J. D., Banov, M., Shekhar, A., Aaronson, S. T., Bardenstein, L., Grecu-Gabos, I., et al. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n1113 · Cited by 87 · cited 1×
“Finally, another RCT compared the efficacy of olanzapine versus valproate or placebo in manic/mixed patients (Tohen et al. 2008).”
ResultSelf-citationMeta-Analysis of the Risk of Subsequent Mood Episodes in Bipolar Disorder
Radua, J., Grunze, H., & Amann, B. L. (2017) · Psychotherapy and Psychosomatics · doi:10.1159/000449417 · Cited by 86 · cited 1×
“A recent meta-analysis of large naturalistic studies confirmed that mixed states beget mixed states: a mixed index episode was in almost half of the cases followed by another mixed episodes (45.9% vs 28% depressive and 26.1% manic) (Radua et al. 2017).”
BackgroundInfluentialSelf-citationAntidepressant-associated chronic irritable dysphoria (ACID) in STEP-BD patients
El‐Mallakh, R. S., Ghaemi, S. N., Sagduyu, K., Thase, M. E., Wisniewski, S. R., Nierenberg, A. A., Zhang, H. W., Pardo, T. A., & Sachs, G. S. (2008) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.03.025 · Cited by 85 · cited 3×
“, long-term antidepressant continuation after a depressive index episode (El-Mallakh et al. 2008), or antipsychotic-induced dysphoria after a manic index episode (Wu and Okusaga 2015).”
BackgroundEffect of comorbid anxiety on treatment response in bipolar depression
Tohen, M., Calabrese, J., Vieta, E., Bowden, C., Gonzalez-Pinto, A., Lin, D., Xu, W., & Corya, S. (2007) · Journal of Affective Disorders · doi:10.1016/j.jad.2007.03.014 · Cited by 84
Self-citationSuppes, T. M., Eudicone, J. M., McQuade, R. D., Pikalov, A., & Carlson, B. X. (2007) · Journal of Affective Disorders · doi:10.1016/j.jad.2007.08.015 · Cited by 83 · cited 3×
“In the combined analysis of the two 3-week acute studies, the most common TEAS that occurred in more patients receiving aripiprazole were somnolence, dyspepsia, akathisia, and accidental injury (Suppes et al. 2008).”
BackgroundInfluentialBordering on bipolar: The overlap between borderline personality and bipolarity
Coulston, C. M., Tanious, M., Mulder, R. T., Porter, R. J., & Malhi, G. S. (2012) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867412445528 · Cited by 81 · cited 1×
“In particular, there is the complexity of parsing mixed states from agitated depression and borderline personality disorder, both as a threshold disorder and a comorbidity, that presents with agitated dysphoria as a normative presentation (Coulston et al. 2012).”
BackgroundLithium treatment of mania: Clinical characteristics, specify of symptom change, and outcome
Swann, A. C., Secunda, S. K., Katz, M. M., Koslow, S. H., Maas, J. W., Chang, S. S., & Robins, E. (1986) · Psychiatry Research · doi:10.1016/0165-1781(86)90025-9 · Cited by 80 · cited 1×
“Manic episodes with or without subsyndromal depression also differ in treatment response (Swann et al. 1997; Swann et al. 2002), severity of anxiety (Swann et al. 1986; Swann et al. 2002) and duration (Pacchiarotti et al. 2011).”
BackgroundYatham, L. N., Vieta, E., Goodwin, G. M., Bourin, M., de Bodinat, C., Laredo, J., & Calabrese, J. (2016) · British Journal of Psychiatry · doi:10.1192/bjp.bp.114.147587 · Cited by 79 · cited 1×
“However, a pivotal RCT in bipolar depression with adjunctive agomelatine failed (Yatham et al. 2016), post hoc analyses suggested contribution of a larger placebo response to the failure of the study.”
ResultSelf-citationBipolar mixed episodes and antidepressants: a cohort study of bipolar I disorder patients
Valentí, M., Pacchiarotti, I., Rosa, A. R., Bonnín, C. M., Popovic, D., Nivoli, A. M. A., Murru, A., Grande, Í., Colom, F., & Vieta, E. (2011) · Bipolar Disorders · doi:10.1111/j.1399-5618.2011.00908.x · Cited by 78 · cited 1×
“Current evidence from prospective or retrospective studies support the notion that mixed patients are at higher risk for a maniform switch (Bottlender et al. 2004; Strejilevich et al. 2011; Valenti et al. 2011; Inoue et al. 2015; Barbuti et al. 2017).”
BackgroundSelf-citationMcIntyre, R. S., Cucchiaro, J., Pikalov, A., Kroger, H., & Loebel, A. (2015) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14m09410 · Cited by 78
Oxcarbazepine as add-on treatment in patients with bipolar manic, mixed or depressive episode
Benedetti, A., Lattanzi, L., Pini, S., Musetti, L., Dell'Osso, L., & Cassano, G. B. (2003) · Journal of Affective Disorders · doi:10.1016/s0165-0327(02)00407-x · Cited by 77 · cited 1×
“There is some evidence from an open 8-week add-on study by Benedetti et al. (2004) that oxcarbazepine has some efficacy in DSM-IV mixed manic states.”
BackgroundExtended-Release Carbamazepine Capsules as Monotherapy in Bipolar Disorder
Weisler, R. H., Hirschfeld, R. M. A., Cutler, A. J., Gazda, T. D., Ketter, T. A., Keck, P. E., Swann, A., & Kalali, A. H. (2006) · CNS Drugs · doi:10.2165/00023210-200620030-00004 · Cited by 76 · cited 2×
“The improvement in manic and depressive symptoms was significant in the mixed subgroup of patients (P< 0.01 and P< 0.05, respectively), while in the case of pure manic patients this was only the case for manic but not depressive symptoms (Weisler et al. 2006).”
BackgroundResultInfluentialGonzález-Pinto, A., Barbeito, S., Alonso, M., Alberich, S., Haidar, M. K., Vieta, E., Tabarés-Seisdedos, R., Zorrilla, I., González-Pinto, M. A., & López, P. (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09m05483yel · Cited by 76
Self-citationDonepezil in treatment-resistant bipolar disorder
Burt, T., Sachs, G. S., & Demopulos, C. M. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00320-5 · Cited by 75 · cited 1×
“Other medication tested in bipolar mixed states Burt et al. (1999) conducted an open-label trial with the cholinesterase inhibitor donepezil add-on in 11 adult patients with a diagnosis of BD-I disorder partially or non-responsive to lithium.”
MethodDiagnosis and treatment of mixed mania
(1987) · American Journal of Psychiatry · doi:10.1176/ajp.144.1.96 · Cited by 75 · cited 1×
“However, the presence of a mixed state may be a predictor of poor response to lithium (Secunda et al. 1987; Swann et al. 1997).”
BackgroundUse of Topiramate in Treatment-Resistant Bipolar Spectrum Disorders
Vieta, E., Torrent, C., García‐Ribas, G., Gilabert, A., García–Parés, G., Rodriguez, A., Cadevall, J., García-Castrillón, J., Lusilla, P., & Arrufat, F. J. (2002) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200208000-00017 · Cited by 74 · cited 1×
“The other open-label study, which recruited bipolar spectrum patients, found that, out of the three mixed subjects, one was responding (50% decrease in both manic and depressive symptoms), while two had a depressive episode relapse and one a mixed relapse (Vieta et al. 2002).”
BackgroundSelf-citationPatkar, A., Gilmer, W., Pae, C.-U., Vöhringer, P. A., Ziffra, M., Pirok, E., Mulligan, M., Filkowski, M. M., Whitham, E. A., Holtzman, N. S., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034757 · Cited by 73 · cited 3×
“Efficacy in acute depressive mixed episodes A 6-week, randomised, placebo-controlled trial enrolled 73 patients with BD-II (n¼ 43) or MDD who met DSM-IV criteria for an MDE together with two or three DSM-IV mania criteria (Patkar et al. 2012).”
BackgroundMethodInfluentialNolen, W. A., & Weisler, R. H. (2013) · Bipolar Disorders · doi:10.1111/bdi.12027 · Cited by 73 · cited 1×
“Patients with a mixed index episode had a significantly lower risk of a relapse into a new manic episode (HR (95% CI) 0.34 (0.12–0.95)) and episode of any type compared to placebo (HR (95% CI) 0.48 (0.27–0.86))(Weisler et al. 2011; Nolen and Weisler 2013).”
BackgroundInfluentialA Pilot Trial of Adjunctive Gabapentin in the Treatment of Bipolar Disorder
McElroy, S. L., Soutullo, C. A., Keck, P. E., et al. (1997) · Annals of Clinical Psychiatry · doi:10.3109/10401239709147781 · Cited by 72
Salvatore, P., Baldessarini, R. J., Centorrino, F., Egli, S., Albert, M., Gerhard, A., & Maggini, C. (2002) · Harvard Review of Psychiatry · doi:10.1080/10673220216283 · Cited by 71 · cited 2×
“In his model, only two variations (either all increased or all diminished) constitute the ‘pure’ poles, the others are mixed states, a concept described more in detail by Wilhelm Weygandt (Weygandt 1899; Salvatore et al. 2002).”
BackgroundPharmacological treatment and risk of psychiatric hospital admission in bipolar disorder
Joas, E., Karanti, A., Song, J., Goodwin, G. M., Lichtenstein, P., & Landén, M. (2017) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.116.187989 · Cited by 71 · cited 8×
“The Swedish registry study by Joas et al. (2017) established a prophylactic effect of lithium and valproate, but not quetiapine, in preventing hospitalisation due to a mixed episode (HR for quetiapine: 0.92 (0.62–1.39)).”
BackgroundResultInfluentialSelf-citationMedda, P., Perugi, G., Zanello, S., Ciuffa, M., Rizzato, S., & Cassano, G. B. (2010) · The Journal of ECT · doi:10.1097/yct.0b013e3181b00f1e · Cited by 70 · cited 1×
“Medda et al. (2010) evaluated the ECT response in a sample of BD-I patients, in which 46 patients exhibited depression and 50 patients demonstrated a mixed state.”
MethodECT in Mixed Affective States: A Case Series
Gruber, N. P., Dilsaver, S. C., Shoaib, A. M., & Swann, A. C. (2000) · The Journal of ECT · doi:10.1097/00124509-200006000-00010 · Cited by 69 · cited 1×
“Gruber et al. (2000) reported a significant reduction in depressive and manic symptoms in a small case series of seven mixed state patients treated with ECT.”
BackgroundEfficacy of valproate versus lithium in mania or mixed mania: a randomized, open 12-week trial
Bowden, C. L., Mosolov, S., Hranov, L., Chen, E., Habil, H., Kongsakon, R., Manfredi, R., & Lin, H.-N. (2010) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e328333ac1b · Cited by 69
Self-citationKetter, T. A., Sarma, K., Silva, R., Kroger, H., Cucchiaro, J., & Loebel, A. (2016) · Depression and Anxiety · doi:10.1002/da.22479 · Cited by 69 · cited 2×
“Patients who completed the controlled acute treatment trials were also eligible for a 6-month open-label extension study (Ketter et al. 2016), which was then prolonged for an additional 18 months of continuation treatment with flexible, once-daily doses of lurasidone in the range of 20–80mg…”
Gabapentin in the acute treatment of refractory bipolar disorder
Altshuler, L. L., Keck Jr, P. E., McElroy, S. L., Suppes, T., Brown, E. S., Denicoff, K., Frye, M., Gitlin, M., Hwang, S., Goodman, R., et al. (1999) · Bipolar Disorders · doi:10.1034/j.1399-5618.1999.10113.x · Cited by 68 · cited 2×
“In another study on BD-I or BD-II patients, inadequately responding to standard therapy, five out of the nine mixed patients included had a positive response although lower and with a time to response longer than for manic or hypomanic patients (Altshuler et al. 1999).”
BackgroundThe clinical epidemiology of pure and mixed manic episodes
Cassidy, F., & Carroll, B. J. (2001) · Bipolar Disorders · doi:10.1034/j.1399-5618.2001.030105.x · Cited by 67 · cited 1×
“…attempts (Dilsaver et al. 1994; Strakowski et al. 1996; Goldberg et al. 1998), longer and more expensive hospitalisations (Gonz alez-Pinto et al. 2010), a longer duration of illness after the first hospitalisation (Cassidy and Carroll 2001), and are more difficult to treat (Kupfer et al. 2000).”
BackgroundHouston, J. P., Tohen, M., Degenhardt, E. K., Jamal, H. H., Liu, L. L. L., & Ketter, T. A. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04895yel · Cited by 67 · cited 1×
“Finally, a 6-week RCT specifically enrolled DSM-IV-TR mixed patients partially non-responsive to 14 days of valproate monotherapy (Houston et al. 2009).”
MethodEpidemiology, Diagnosis and Management of Mixed Mania
lez-Pinto, A. G., Aldama, A., Mosquera, F., & mez, C. G. L. G. (2007) · CNS Drugs · doi:10.2165/00023210-200721080-00001 · Cited by 66
Berwaerts, J., Xu, H., Nuamah, I. F., Lim, P., & Hough, D. W. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.06.030 · Cited by 66
The role of gender in mixed mania
Arnold, L. M., McElroy, S. L., & Keck, P. E. (2000) · Comprehensive Psychiatry · doi:10.1016/s0010-440x(00)90137-8 · Cited by 66 · cited 2×
“…and bipolar spectrum disorder, have been described in the literature: greater female prevalence (Dell'Osso et al. 1991; Akiskal et al. 1998; Arnold et al. 2000), especially in mixed hypomanic patients (Suppes et al. 2005), younger age at onset and more recurrences during follow-up (Gonz…”
BackgroundHantouche, E. G., Akiskal, H. S., Azorin, J., Châtenet-Duchêne, L., & Lancrenon, S. (2005) · Journal of Affective Disorders · doi:10.1016/j.jad.2005.01.005 · Cited by 66 · cited 2×
“Patients with mixed mania have higher rates of recurrence (Hantouche et al. 2006; Tundo et al. 2015), psychiatric re-admissions (Perugi et al. 2000; Gonz alezPinto et al. 2011), more frequent prior suicide attempts (Dilsaver et al. 1994; Strakowski et al. 1996; Goldberg et al. 1998), longer and…”
BackgroundSelf-citationElectroconvulsive therapy in the treatment of mixed states in bipolar disorder
Valentí, M., Benabarre, A., García-Amador, M., Molina, O., Bernardo, M., & Vieta, E. (2008) · European Psychiatry · doi:10.1016/j.eurpsy.2007.10.011 · Cited by 66 · cited 1×
“But evidence from several case series suggest that ECT is effective in the treatment of acute mixed episodes (Valenti et al. 2008).”
BackgroundSelf-citationSzegedi, A., Durgam, S., Mackle, M., Yu, S. Y., Wu, X., Mathews, M., & Landbloom, R. P. (2018) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2017.16040419 · Cited by 66
Benazzi, F., Berk, M., Frye, M. A., Wang, W., Barraco, A., & Tohen, M. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04772gre · Cited by 65 · cited 2×
“No worsening of mania was seen among the fluoxetinetreated patients (Benazzi et al. 2009).”
BackgroundMethodSuppes, T., Kroger, H., Pikalov, A., & Loebel, A. (2016) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2016.03.012 · Cited by 65
Topiramate - Safety and Tolerability
Jones, M. W. (1998) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100034855 · Cited by 65 · cited 1×
“However, neurological side effects are not entirely dose dependent, including cognitive impairment and rare cases of transient hemiparesis (Jones 1998).”
BackgroundDysthymic and cyclothymic depressions: therapeutic considerations.
Hs, A. (1994) · PubMed · Cited by 64
Carlson, B. X., Ketter, T. A., Sun, W., Timko, K., McQuade, R. D., Sanchez, R., Vester‐Blokland, E., & Marcus, R. (2012) · Bipolar Disorders · doi:10.1111/j.1399-5618.2011.00974.x · Cited by 63 · cited 2×
“Post hoc interaction analysis of a 52-week study testing aripiprazoleþ lamotrigine versus placeboþ lamotrigine (Carlson et al. 2012) demonstrated that there were differential treatment effects according to a patient’s index episode, manic or mixed presentation, for time to depressive episode (P¼…”
BackgroundSzegedi, A., Zhao, J., van Willigenburg, A., Nations, K. R., Mackle, M., & Panagides, J. (2011) · BMC Psychiatry · doi:10.1186/1471-244x-11-101 · Cited by 63 · cited 5×
“A combined post hoc analysis of the two acute studies reporting on the whole mixed population of 302 patients analysed DSM-IV mixed patients as a separate group, and in addition subgroups of patients with significant depressive symptoms as defined by the authors (MADRS total score 20 or Clinical Global Impression for…”
BackgroundMethodInfluentialBarbuti, M., Pacchiarotti, I., Vieta, E., Azorin, J., Angst, J., Bowden, C. L., Mosolov, S. N., Young, A. H., & Perugi, G. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.05.035 · Cited by 63 · cited 2×
“In addition, MDD-AIHM patients had more than three episodes more frequently and reported higher rates of treatment resistance, mood lability and irritability following treatment with antidepressants (Barbuti et al. 2017).”
BackgroundSelf-citationAcute Dysphoric Mania: Treatment Response to Olanzapine Versus Placebo
Baker, R. W., Tohen, M., Fawcett, J., Risser, R. C., Schuh, L. M., Brown, E., Stauffer, V. L., Shao, L., & Tollefson, G. D. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200304000-00005 · Cited by 62 · cited 1×
“The other study (Baker et al. 2003) focussed on those patients with moderate-to-severe depressive symptoms (or dysphoric, defined by a HAM-D score 20 at baseline; n¼ 68), and compared them against the nondysphoric patients (n¼ 178).”
ResultShim, I. H., Woo, Y. S., & Bahk, W. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.10.061 · Cited by 62 · cited 1×
“(Shim et al. 2015).”
Azorin, J.-M., Aubrun, E., Bertsch, J., Reed, C., Gerard, S., & Lukasiewicz, M. (2009) · BMC Psychiatry · doi:10.1186/1471-244x-9-33 · Cited by 62 · cited 2×
“Almost all guidelines recommend not initiating antidepressants when a mixed state is diagnosed, although in clinical practice they remain widely prescribed in combination with antimanic agents for the treatment of mixed states (Azorin et al. 2009).”
BackgroundSelf-citationKetter, T. A., Kalali, A. H., Weisler, R. H., & SPD417 Study Group (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0511 · Cited by 61
Pure and mixed manic subtypes: a review of diagnostic classification and validation
Cassidy, F., Yatham, L. N., Berk, M., & Grof, P. (2008) · Bipolar Disorders · doi:10.1111/j.1399-5618.2007.00558.x · Cited by 61 · cited 1×
“A major problem for including mixed states in studies is the lack of a generally accepted definition (Gonz alez-Pinto et al. 2003; Cassidy et al. 2008; Vieta and Morralla 2010; Swann et al. 2013).”
BackgroundSelf-citationIntravenous Valproate Loading in Acutely Manic and Depressed Bipolar I Patients
Grunze, H., Erfurth, A., Amann, B. L., Giupponi, G., Kammerer, C., & Walden, J. (1999) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199908000-00003 · Cited by 61 · cited 1×
“Four of seven patients were classified as responders as far as a reduction of manic symptoms and overall improvement are concerned, only the rapid cycling patient and the two depressed patients did not improve (Grunze et al. 1999).”
BackgroundSelf-citationOlanzapine Versus Placebo in Acute Mania: Treatment Responses in Subgroups
Baldessarini, R. J., Hennen, J., Wilson, M., Calabrese, J., Chengappa, R., Keck, P. E., McElroy, S. L., Sachs, G., Vieta, E., Welge, J. A., et al. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000085410.08426.9a · Cited by 61 · cited 2×
“was superior to placebo in improving both manic and depressive symptoms in both mixed (n1⁄4 73) and nonmixed patients (n1⁄4 181) (Baldessarini et al. 2003).”
BackgroundResultSelf-citationMcIntyre, R. S., Tohen, M., Berk, M., Zhao, J., & Weiller, E. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.04.025 · Cited by 60 · cited 4×
“Given the broader definition of mixed states in the DSM-5, it is not surprising that the prevalence of mixed states is higher when DSM-5 is used to diagnose patients instead of DSM-IV.”
BackgroundMethodInfluentialEfficacy of olanzapine combined with valproate or lithium in the treatment of dysphoric mania
Baker, R. W., Brown, E., Akiskal, H. S., Calabrese, J. R., Ketter, T. A., Schuh, L. M., Trzepacz, P. T., Watkin, J. G., & Tohen, M. (2004) · British Journal of Psychiatry · doi:10.1192/bjp.185.6.472 · Cited by 58 · cited 2×
“A secondary post hoc analysis (Baker et al. 2004) of this original study selected 85 patients with mania or a mixed episode who had substantial comorbid depression at baseline, also defined as a HAM-D score 20 (dysphoric mania), and compared the efficacy of adjunctive olanzapine versus…”
BackgroundVieta, E., Grunze, H., Azorin, J.-M., & Fagiolini, A. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.12.031 · Cited by 57 · cited 3×
“Estimates suggest that about one-third of all manic episodes meet the criteria for a DSM-5 manic episode with mixed features (Vieta et al. 2014; Young and Eberhard 2015; Reinares et al. 2015).”
BackgroundSelf-citation
Research works printed but not linked: 33
- Akiskal HS., 1994, J Clin Psychiatry, 55, 46
- American Psychiatric Association, 1994, Diagnostic and statistical manual of mental disorders
- Baillarger J., 1854, Folie à double forme
- 10.1001/jama.271.12.918 · doi:10.1001/jama.271.12.918 · Paper page
- Cipriani A, 2013, Cochrane Database Syst Rev, 10, CD003196
- Citrome L., 2014, Expert Opin Drug Saf, 13, 803
- Ernst CL, 2002, J Clin Psychiatry, 63, 42
- Falret JP., 1854, Bull Acad Natl Méd, 19, 382
- Garcia-Bonetto GM, 2009, Archivos De Neurosci, 14, 215
- Himmelhoch JM, 1986, Psychopharmacol Bull, 22, 613
- Kraepelin E., 1899, Ein Lehrbuch für Studierende und Ärzte
- Mazzarini L, 2017, J Affect Disord
- McIntyre RS, 2011, Prim Care Companion CNS Disord, 13, CC
- Mokhber N, 2008, Neuropsychiatr Dis Treat, 4, 227
- Mosolov SN, 2009, Zh Nevrol Psikhiatr Im S S Korsakova, 109, 47
- Mosolov SN, 2009, Zh Nevrol Psikhiatr Im S S Korsakova, 109, 36
- Mosolov SN, 1990, Zh Nevropatol Psikhiatr Im S S Korsakova, 90, 121
- Mosolov SN., 1991, Zh Nevropatol Psikhiatr Im S S Korsakova, 91, 78
- Palma M, 2016, Depress Res Treat, 2016, 8306071
- Pichot P., 2004, Bull Acad Natl Med, 188, 275
- Pigott K, 2016, Cochrane Database Syst Rev, 9, CD003384
- Sharma V, 1999, J Psychiatry Neurosci, 24, 40
- 10.3109/10401239909147073 · doi:10.3109/10401239909147073
- Spitzer RL, 1975, Research diagnostic criteria (RDC) for a selected group of functional disorders
- Strejilevich SA, 2011, Ann Clin Psychiatry, 23, 186
- Strömgren LS., 1988, Convuls Ther, 4, 306
- Vanelle JM, 1994, Convuls Ther, 10, 195
- Vieta E, 1995, Int J Neuropsychopharmacol, 10, 491
- Whittier MC, 1995, J Clin Psychiatry, 56, 590
- Wilhelm S, 2007, Eur Psychiatry, 22, S 262
- World Health Organization, 1992, Clinical descriptions and diagnostic guidelines
- Zeeuws D, 2010, Psychiatr Danub, 22, S135
- Zeeuws D, 2010, Psychiatr Danub, 22, S164
Cited by
McIntyre, R. S., Berk, M., Brietzke, E., Goldstein, B. I., López-Jaramillo, C., Kessing, L. V., Malhi, G. S., Nierenberg, A. A., Rosenblat, J. D., Majeed, A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31544-0 · Cited by 1,047
Self-citationMcAllister-Williams, R. H., Arango, C., Blier, P., Demyttenaere, K., Falkai, P., Gorwood, P., Hopwood, M., Javed, A., Kasper, S., Malhi, G. S., et al. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.02.023 · Cited by 278
Self-citationStahl, S. M., Laredo, S., & Morrissette, D. A. (2020) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320905752 · Cited by 223
Nuñez, N. A., Joseph, B., Pahwa, M., Kumar, R., Resendez, M. G., Prokop, L. J., Veldic, M., Seshadri, A., Biernacka, J. M., Frye, M. A., et al. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.12.134 · Cited by 215
The Economic Burden of Bipolar Disorder in the United States: A Systematic Literature Review
Bessonova, L., Ogden, K., Doane, M. J., O'Sullivan, A. K., & Tohen, M. (2020) · ClinicoEconomics and Outcomes Research · doi:10.2147/ceor.s259338 · Cited by 147
Metadata
- Authors
- Grunze, H., Vieta, E., Goodwin, G. M., Bowden, C., Licht, R. W., Azorin, J.-M., Yatham, L., Mosolov, S., Möller, H.-J., Kasper, S., & on behalf of the Members of the WFSBP Task Force on Bipolar Affective Disorders Working on this topic
- Affiliations
- Klinikum am Weissenhof (DE)
- Centro de Investigación Biomédica en Red de Salud Mental (ES)
- Warneford Hospital (GB)
- The University of Texas at San Antonio Health Science Center (US)
- Aalborg University Hospital (DK)
- Hôpital Sainte-Marguerite (FR)
- University of British Columbia (CA)
- Department for Therapy of Mental Disorders, Moscow Research Institute of Psychiatry, Moscow, Russia;
- Ludwig-Maximilians-Universität München (DE)
- Medical University of Vienna (AT)
- Corresponding author
- Grunze, Heinz
- ORCID
- Venue
- The World Journal of Biological Psychiatry
- Publisher
- Informa UK Limited
- Published
- 2017-11-03
- Volume
- 19
- Issue
- 1
- Pages
- 2-58
- ISSN
- 1562-2975 (ISSN-L)
- 1814-1412
- OpenAlex
- W2766127294
- Cited by
- 187
- References
- 335
- Citations by year
- 2026: 12 · 2025: 21 · 2024: 16 · 2023: 19 · 2022: 24 · 2021: 28 · 2020: 30 · 2019: 25 · 2018: 10 · 2017: 1
- FWCI
- 2.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The World Journal of Biological Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- HAL AMU (submittedVersion)
- VBN Forskningsportal (Aalborg Universitet) (submittedVersion)
- Funders
- National Institute for Health and Care Research (NF-SI-0513-10010)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- bipolar disorder, acute treatment, long-term maintenance therapy, atypical antipsychotics, olanzapine, quetiapine, ziprasidone, valproic acid, lithium, recurrence prevention, manic symptoms, depressive symptoms
- MeSH terms
- Biological Psychiatry, Bipolar Disorder, Electroconvulsive Therapy, Humans, Societies, Medical, Antipsychotic Agents, Practice Guidelines as Topic, Antimanic Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.